Keenova Therapeutics plc Operating Lease Liability
Keenova Therapeutics plc had Operating Lease Liability of $60.60 million as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-04-15
- 2025-12-31: Operating Lease, Liability $60.60M.
- 2024-12-27: Operating Lease, Liability $22.80M; Operating Lease, Liability as first filed $55.80M.
- 2023-12-29: Operating Lease, Liability $55.30M.
- 2022-12-30: Operating Lease, Liability $40.70M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2025-12-31 | $60.60M 10-K · filed 2026-04-15 | |
| 2024-12-27 | $22.80M 10-K · filed 2026-04-15 | $55.80M 10-K · filed 2025-03-13 |
| 2023-12-29 | $55.30M 10-K · filed 2024-03-26 | |
| 2022-12-30 | $40.70M 10-K · filed 2024-03-26 | |
| 2021-12-31 | $31.50M 10-K · filed 2023-03-03 | |
| 2019-12-27 | $89.40M 10-K · filed 2020-02-26 | |
| 2019-09-27 | $90.90M 10-Q · filed 2019-11-05 | |
| 2019-06-28 | $97.30M 10-Q · filed 2019-08-06 | |
| 2019-03-29 | $96.70M 10-Q · filed 2019-05-07 |